Subscribe
Logo small
Search

Targeted approach to prostate cancer treatment

MedExpress Team

medexpress.pl

Published June 26, 2024 17:05

Targeted approach to prostate cancer treatment - Header image
Fot. Thinkstock/Getty Images
Prostate cancer is the most common cancer in men and one of the most dangerous. The medical advances that have been made in the treatment and diagnosis of prostate cancer are enormous. Systemic changes must keep up with it, but for that, we need to change the way we think and approach prostate cancer in a new way.

Not so long ago it was said that 22,000 new cases of the disease are diagnosed annually in Poland, and there are about 5,500 deaths. Now it is estimated that these new cases could be as many as 25 thousand. This is a challenge for the health care system. With better and better treatment, patients are living longer and better.

The most important risk factors are age, race, lifestyle and oncologic family history. As in any disease, so in prostate cancer, diagnosis is key. It is well known: the earlier - the better, as the method and treatment options largely depend on the stage of the disease. - Nearly 25 percent of newly diagnosed patients have already metastasized, says Jakub Zolnierek, MD, clinical oncologist, and adds that in Western countries this percentage is much lower. In the case of disseminated p...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!

Read also